Abstract
Purpose
Serum-negative-chronic-autoimmune-thyroiditis (SN-CAT) is considered a milder variant of classic Hashimoto’s thyroiditis (CHT). However, its prevalence remains unknown and it is still unclear whether SN-CAT behaves differently in terms of l-thyroxine (LT4) substitution treatment of hypothyroidism. Aims of this study were to estimate the prevalence of SN-CAT in a large series of hypothyroid patients and to compare LT4 requirements in hypothyroid patients with SN-CAT and CHT.
Methods
Five-hundred-eighty-one consecutive patients with primary-autoimmune-hypothyroidism were enrolled in a cross-sectional study. LT4 requirements and thyroid-volume changes were longitudinally evaluated in 49 hypothyroid patients with SN-CAT and in 98 sex and age-matched hypothyroid patients with CHT.
Results
In our series the prevalence of SN-CAT was 20.8%. At diagnosis, patients in the CHT and SN-CAT groups had similar male/female ratio, age and BMI, while serum TSH and thyroid-volume were significantly greater in the CHT group. In the longitudinal study, during a follow-up of 8.9 ± 4.6 years, 8 out of 49 (16.3%) SN-CAT patients developed positive tests for of circulating TPO-Ab and/or Tg-Ab. Thyroid-volume significantly decreased in CHT patients, but not in those with SN-CAT. The maximum daily substitution dose of LT4 was smaller in SN-CAT patients as compared with the CHT ones. Multivariate analysis showed that age, BMI, basal TSH and thyroid antibody status independently and significantly predicted the maximum daily substitution dose of LT4.
Conclusions
SN-CAT accounts for a significant proportion of patients with autoimmune hypothyroidism. Compared with hypothyroid patients diagnosed with CHT, the SN-CAT ones require smaller doses of LT4 to correct their hypothyroidism.
Similar content being viewed by others
References
Rotondi M, Coperchini F, Magri F, Chiovato L (2014) Serum-negative autoimmune thyroiditis: what's in a name? J Endocrinol Invest 37(6):589–591. https://doi.org/10.1007/s40618-014-0083-8
Baker JR, Saunders NB, Wartofsky L, Tseng YC, Burman KD (1988) Seronegative Hashimoto thyroiditis with thyroid autoantibody production localized to the thyroid. Ann Intern Med 108(1):26–30
Zhang DM, Zhou ZG, Zhang C et al (2004) Subclassification of seronegative type 1 diabetic subjects with HLA-DQ genotypes. Zhonghua Nei Ke Za Zhi 43(3):174–178
Punzi L, Schiavon F, Ramonda R, Cavasin F, Ruffatti A, Todesco S (1991) Anti-thyroid microsomal antibody in synovial fluid as a revealing feature of seronegative autoimmune thyroiditis. Clin Rheumatol 10(2):181–183
Spina MP, Cerri A, Piacentini V, Stringa A, Visca U (1990) Seronegative hashitoxicosis in patient with rheumatoid arthritis. Minerva Endocrinol 15(3):173–176
Takamatsu J, Yoshida S, Yokozawa T et al (1998) Correlation of antithyroglobulin and antithyroid-peroxidase antibody profiles with clinical and ultrasound characteristics of chronic thyroiditis. Thyroid 8(12):1101–1106. https://doi.org/10.1089/thy.1998.8.1101
Mariotti S, Anelli S, Ruf J et al (1987) Comparison of serum thyroid microsomal and thyroid peroxidase autoantibodies in thyroid diseases. J Clin Endocrinol Metab 65(5):987–993. https://doi.org/10.1210/jcem-65-5-987
Mariotti S, Chiovato L, Vitti P et al (1989) Recent advances in the understanding of humoral and cellular mechanisms implicated in thyroid autoimmune disorders. Clin Immunol Immunopathol 50(1 Pt 2):S73–84
Pearce EN, Farwell AP, Braverman LE (2003) Thyroiditis. N Engl J Med 348(26):2646–2655. https://doi.org/10.1056/NEJMra021194
O'Leary PC, Feddema PH, Michelangeli VP et al (2006) Investigations of thyroid hormones and antibodies based on a community health survey: the Busselton thyroid study. Clin Endocrinol (Oxf) 64(1):97–104. https://doi.org/10.1111/j.1365-2265.2005.02424.x
Bülow Pedersen I, Laurberg P, Knudsen N et al (2005) A population study of the association between thyroid autoantibodies in serum and abnormalities in thyroid function and structure. Clin Endocrinol (Oxf) 62(6):713–720. https://doi.org/10.1111/j.1365-2265.2005.02284.x
Rotondi M, de Martinis L, Coperchini F et al (2014) Serum negative autoimmune thyroiditis displays a milder clinical picture compared with classic Hashimoto's thyroiditis. Eur J Endocrinol 171(1):31–36. https://doi.org/10.1530/EJE-14-0147
Iadarola C, Croce L, Quaquarini E et al (2018) Nivolumab induced thyroid dysfunction: unusual clinical presentation and challenging diagnosis. Front Endocrinol (Lausanne) 9:813. https://doi.org/10.3389/fendo.2018.00813
Burch HB (2019) Drug effects on the thyroid. N Engl J Med 381(8):749–761. https://doi.org/10.1056/NEJMra1901214
Rotondi M, Cappelli C, Leporati P et al (2010) A hypoechoic pattern of the thyroid at ultrasound does not indicate autoimmune thyroid diseases in patients with morbid obesity. Eur J Endocrinol 163(1):105–109. https://doi.org/10.1530/EJE-10-0288
Mariotti S, Caturegli P, Piccolo P, Barbesino G, Pinchera A (1990) Antithyroid peroxidase autoantibodies in thyroid diseases. J Clin Endocrinol Metab 71(3):661–669. https://doi.org/10.1210/jcem-71-3-661
Rotondi M, Magri F, Chiovato L (2011) Thyroid and obesity: not a one-way interaction. J Clin Endocrinol Metab. 96:344–346
Rotondi M, Leporati P, La Manna A et al (2009) Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism? Eur J Endocrinol 160(3):403–408. https://doi.org/10.1530/EJE-08-0734
Radetti G, Kleon W, Buzi F et al (2008) Thyroid function and structure are affected in childhood obesity. J Clin Endocrinol Metab 93(12):4749–4754. https://doi.org/10.1210/jc.2008-0823
Haymart MR, Banerjee M, Reyes-Gastelum D, Caoili E, Norton EC (2019) Thyroid ultrasound and the increase in diagnosis of low-risk thyroid cancer. J Clin Endocrinol Metab 104(3):785–792. https://doi.org/10.1210/jc.2018-01933
Dal Maso L, Panato C, Franceschi S et al (2018) The impact of overdiagnosis on thyroid cancer epidemic in Italy, 1998–2012. Eur J Cancer 94:6–15. https://doi.org/10.1016/j.ejca.2018.01.083
Rago T, Chiovato L, Grasso L, Pinchera A, Vitti P (2001) Thyroid ultrasonography as a tool for detecting thyroid autoimmune diseases and predicting thyroid dsfunction in apparently healthy subjects. J Endocrinol Invest 24(10):763–769
Marcocci C, Vitti P, Cetani F, Catalano F, Concetti R, Pinchera A (1991) Thyroid ultrasonography helps to identify patients with diffuse lymphocytic thyroiditis who are prone to develop hypothyroidism. J Clin Endocrinol Metab 72(1):209–213. https://doi.org/10.1210/jcem-72-1-209
Raber W, Gessl A, Nowotny P, Vierhapper H (2002) Thyroid ultrasound versus antithyroid peroxidase antibody determination: a cohort study of four hundred fifty-one subjects. Thyroid 12(8):725–731. https://doi.org/10.1089/105072502760258712
Devdhar M, Drooger R, Pehlivanova M, Singh G, Jonklaas J (2011) Levothyroxine replacement doses are affected by gender and weight, but not age. Thyroid 21(8):821–827. https://doi.org/10.1089/thy.2011.0029
Santini F, Pinchera A, Marsili A et al (2005) Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases. J Clin Endocrinol Metab 90(1):124–127. https://doi.org/10.1210/jc.2004-1306
Ruggeri RM, Trimarchi F, Biondi B (2017) Management of endocrine disease: l-thyroxine replacement therapy in the frail elderly: a challenge in clinical practice. Eur J Endocrinol 177(4):R199–R217. https://doi.org/10.1530/EJE-17-0321
Magri F, Chiovato L, Croce L, Rotondi M (2019) Thyroid hormone therapy for subclinical hypothyroidism. Endocrine 66(1):27–34. https://doi.org/10.1007/s12020-019-02039-z
McLachlan SM, Rapoport B (2013) Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa. Thyroid 23(1):14–24. https://doi.org/10.1089/thy.2012.0374
Rotondi M, Molteni M, Leporati P, Capelli V, Marinò M, Chiovato L (2017) Autoimmune thyroid diseases in patients treated with alemtuzumab for multiple sclerosis: an example of selective anti-TSH-receptor immune response. Front Endocrinol (Lausanne) 8:254. https://doi.org/10.3389/fendo.2017.00254
Michalek K, Morshed SA, Latif R, Davies TF (2009) TSH receptor autoantibodies. Autoimmun Rev 9(2):113–116. https://doi.org/10.1016/j.autrev.2009.03.012
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no financial disclosure of conflicts to report.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants involved in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Croce, L., De Martinis, L., Pinto, S. et al. Compared with classic Hashimoto’s thyroiditis, chronic autoimmune serum-negative thyroiditis requires a lower substitution dose of l-thyroxine to correct hypothyroidism. J Endocrinol Invest 43, 1631–1636 (2020). https://doi.org/10.1007/s40618-020-01249-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-020-01249-x